Hudson Bay Capital Management LP Regenxbio Inc. Transaction History
Hudson Bay Capital Management LP
- $18.6 Billion
- Q2 2024
A detailed history of Hudson Bay Capital Management LP transactions in Regenxbio Inc. stock. As of the latest transaction made, Hudson Bay Capital Management LP holds 165,000 shares of RGNX stock, worth $1.54 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
165,000
Previous 44,900
267.48%
Holding current value
$1.54 Million
Previous $946,000
104.02%
% of portfolio
0.01%
Previous 0.01%
Shares
24 transactions
Others Institutions Holding RGNX
# of Institutions
193Shares Held
43.5MCall Options Held
58.9KPut Options Held
58.4K-
Black Rock Inc. New York, NY8.61MShares$80.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.11MShares$47.8 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.57MShares$42.7 Million3.49% of portfolio
-
Jpmorgan Chase & CO New York, NY3.01MShares$28.2 Million0.0% of portfolio
-
State Street Corp Boston, MA2.87MShares$26.9 Million0.0% of portfolio
About REGENXBIO Inc.
- Ticker RGNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,230,000
- Market Cap $404M
- Description
- REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...